Transgenic human ES and iPS reporter cell lines for identification and selection of pluripotent stem cells in vitro

Stem Cell Research

Volumn 13, Issue 2, 2014, Pages 251-261

  Ovchinnikov, Dmitry A ^a   Titmarsh, Drew M ^a   Fortuna, Patrick R J ^a   Hidalgo, Alejandro ^a   Alharbi, Samah ^a   Whitworth, Deanne J ^a   Cooper White, Justin J ^a   Wolvetang, Ernst J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EOMES PROTEIN; GAPDH PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PUROMYCIN; RETINOIC ACID; SOX2 2 PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRA 1 60 PROTEIN; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ENHANCED GREEN FLUORESCENT PROTEIN; GENETIC MARKER; GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL SELECTION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GERM LAYER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; KARYOTYPE; MICROFLUIDICS; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; UPREGULATION; ANTIBIOTIC RESISTANCE; BIOREACTOR; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CULTURE TECHNIQUE; DEVICES; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC MARKER; GENETIC TRANSDUCTION; GENETICS; GENOTYPE; LENTIVIRINAE; METABOLISM; MICROFLUIDIC ANALYSIS; PHENOTYPE; REPORTER GENE; TIME; TRANSGENE;

ANTI-BACTERIAL AGENTS; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DRUG RESISTANCE, BACTERIAL; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; GENETIC MARKERS; GENETIC VECTORS; GENOTYPE; GREEN FLUORESCENT PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PHENOTYPE; PUROMYCIN; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84928733235     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.05.006     Document Type: Article

References (27)

1. Alvarez C.V., Garcia-Lavandeira M., Garcia-Rendueles M.E., Diaz-Rodriguez E., Garcia-Rendueles A.R., Perez-Romero S., Vila T.V., Rodrigues J.S., Lear P.V., Bravo S.B. Defining stem cell types: Understanding the therapeutic potential of ESCs, ASCs, and iPS cells. J. Mol. Endocrinol. 2012, 49:R89-R111.
2. Briggs J.A., Sun J., Shepherd J., Ovchinnikov D.A., Chung T.L., Nayler S.P., Kao L.P., Morrow C.A., Thakar N.Y., Soo S.Y., et al. Integration-free induced pluripotent stem cells model genetic and neural developmental features of Down syndrome etiology. Stem Cells 2012, 31:467-478.
3. Chung T.L., Turner J.P., Thaker N.Y., Kolle G., Cooper-White J.J., Grimmond S.M., Pera M.F., Wolvetang E.J. Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells. Stem Cells 2010, 28:1782-1793.
4. Corish P., Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 1999, 12:1035-1040.
5. Cubitt A.B., Heim R., Adams S.R., Boyd A.E., Gross L.A., Tsien R.Y. Understanding, improving and using green fluorescent proteins. Trends Biochem. Sci. 1995, 20:448-455.
6. Hotta A., Cheung A.Y., Farra N., Garcha K., Chang W.Y., Pasceri P., Stanford W.L., Ellis J. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat. Protoc. 2009, 4:1828-1844.
7. Hotta A., Cheung A.Y., Farra N., Vijayaragavan K., Seguin C.A., Draper J.S., Pasceri P., Maksakova I.A., Mager D.L., Rossant J., et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 2009, 6:370-376.
8. Hough S.R., Laslett A.L., Grimmond S.B., Kolle G., Pera M.F. A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS One 2009, 4:e7708.
9. Hudson J., Titmarsh D., Hidalgo A., Wolvetang E., Cooper-White J. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev. 2012, 21:1513-1523.
10. Inoue H., Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin. Pharmacol. Ther. 2011, 89:655-661.
11. Keller G. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev. 2005, 19:1129-1155.
12. Lepski G. What do we know about the neurogenic potential of different stem cell types?. Arq. Neuropsiquiatr. 2012, 70:540-546.
13. Liew C.G., Draper J.S., Walsh J., Moore H., Andrews P.W. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007, 25:1521-1528.
14. Liu Y., Jiang P., Deng W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat. Protoc. 2011, 6:640-655.
15. McDonald J.H. Handbook of Biological Statistics 2009, Sparky House Publishing, Baltimore, Maryland. 2nd edn.
16. Nayler S., Gatei M., Kozlov S., Gatti R., Mar J.C., Wells C.A., Lavin M., Wolvetang E. Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl. Med. 2012, 1:523-535.
17. Ovchinnikov D.A., Turner J.P., Titmarsh D.M., Thakar N.Y., Sin D.C., Cooper-White J.J., Wolvetang E.J. Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J. Stem Cells 2012, 4:71-79.
18. Pera M.F. Stem cells: The dark side of induced pluripotency. Nature 2011, 471:46-47.
19. Rowntree R.K., McNeish J.D. Induced pluripotent stem cells: Opportunities as research and development tools in 21st century drug discovery. Regen. Med. 2010, 5:557-568.
20. Titmarsh D.M., Hudson J.E., Hidalgo A., Elefanty A.G., Stanley E.G., Wolvetang E.J., Cooper-White J.J. Microbioreactor arrays for full factorial screening of exogenous and paracrine factors in human embryonic stem cell differentiation. PLoS One 2012, 7:e52405.
21. Titmarsh D.M., Ovchinnikov D.A., Wolvetang E.J., Cooper-White J.J. Full factorial screening of human embryonic stem cell maintenance with multiplexed microbioreactor arrays. Biotechnol. J. 2013, 8:822-834.
22. Tobin S.C., Kim K. Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogramming. FEBS Lett. 2012, 586:2874-2881.
23. Ungrin M.D., Joshi C., Nica A., Bauwens C., Zandstra P.W. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 2008, 3:e1565.
24. Whitworth D.J., Ovchinnikov D.A., Wolvetang E.J. Generation and characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev. 2012, 21:2288-2297.
25. Xia X., Zhang Y., Zieth C.R., Zhang S.C. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 2007, 16:167-176.
26. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009, 5:97-110.
27. Zwaka T.P., Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 2003, 21:319-321.